6th Biobanking Conference and Exhibition

The upcoming proposed Data Protection Regulation in the EU is the culmination of biobanking operations and will constitute a new legal framework if and once passed but the European Commission. As such, SMi's 6th Biobanking Conference will focus on the potential changes and impacts of maintaining a sustainable biobanking infrastructure, harmonisation and interaction between biobanks across UK, Europe and the world.

Expert speaker panel line-up includes the European Commission, MHRA, UK Biobank, Roslin Cell Sciences, European Culture Collection ECACC, European Commission and other leading European Biobanks.

2016 AGENDA HIGHLIGHTS
-Spotlight session: creating a biobank for drug discovery
-Hear the latest updates on Data Protection Act from European Commission and UK Biobank
-Learn about the integration of biobanking in drug development
-Obtain an overview of how to build a model of next generation biobank
-Discover the latest updates on biobanking in the 21st Century

Our expert speaker panel includes:
-Emma Snapes, Biobank Manager, Infant Biobank
-Dr Brian Thomson, Director and Clinical Lead for 100K Genome Project, Nottingham Health Science Biobank
-Professor Glyn Stacey, Director, UK Stem Cell Bank, Division of Advanced Therapies, National Institute for Biological Standards and Control – MHRA
-Octavi Quintana Trias, Principal advisor of DG, European Commission
-Dr Julia Riedlinger, Head of Marker Scouting and Sample Bank, Roche Diagnostics
-Arthur Lewis, Senior RandD Manager, MedImmune
-Dr Michael Luntang-Jensen, Biobank Manager, H. Lundbeck A/S
-Jonathan Sellors, Legal Counsel, UK Biobank